Multivalvular Disease: Percutaneous Management in 2019 and Beyond
Patients with multivalvular disease (MVD) are common and often present with heterogeneous valve defects. Evaluation is complicated by interactions among various valve pathologies. Trials and guidelines focus primarily on single-valve disease, providing few recommendations for the treatment of patien...
Guardado en:
Autores principales: | Magdalena Erlebach, Rüdiger Lange |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Radcliffe Medical Media
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/81d87deb3f12433da9dfc3a9365d8cfa |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Management of Valvular Disease During Pregnancy: Evolving Role of Percutaneous Treatment
por: Chiara Fraccaro, et al.
Publicado: (2020) -
Beyond angiogram! Impact of IVUS on revascularization of complex coronary artery disease
por: Shruti S. Kolli, et al.
Publicado: (2021) -
Diagnostic Angiograms and Percutaneous Coronary Interventions in Pregnancy
por: Phyo Htet Khaing, et al.
Publicado: (2020) -
Management of Acute Coronary Syndromes During the Coronavirus Disease 2019 Pandemic: Deviations from Guidelines and Pragmatic Considerations for Patients and Healthcare Workers
por: Henry Seligman, et al.
Publicado: (2020) -
Short-term outcomes in IVUS-guided ultra low contrast percutaneous coronary intervention in chronic kidney disease patients
por: Ashiti Jain, et al.
Publicado: (2021)